Deciphering biology,
discovering new anti-infectives

through deep phenotypic insights and machine learning


Discovering new classes of anti-infectives to overcome drug resistant infections.

Our machine learning (ML)-based imaging platform for anti-infective drug discovery enables rapid and highly efficient identification of compounds with new and unexploited mechanisms of action at the very outset of the discovery process.

Our combined expertise, cutting edge technologies and novel workflows enable a rapid and early understanding of a compound’s mechanism of action, the potential addressable target product profile, and clinical utility based on deep analysis of cell behavior.

Explore Platform

Delivering new classes of anti-infectives.

ArrePath is applying its technology platform to develop a pipeline of new classes of antibiotics,
targeting unexploited and under-exploited mechanisms of action, to address unmet clinical need and overcome drug resistance.

Discover Strategy

Recent News and Updates